Vitro Biopharma, Inc. (VTRO)

Vitro Biopharma will go public soon, but the exact IPO date is still unknown.

IPO Price

$15.00

Shares Offered

2,179,344

Deal Size

$32.69M

Vitro Biopharma Income Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Year	2021	2020
Revenue	1.31	0.65
Revenue Growth (YoY)	102.09%	-
Cost of Revenue	0.35	0.22
Gross Profit	0.96	0.43
Selling, General & Admin	4.96	1.7
Research & Development	0.12	-
Operating Expenses	5.08	1.7
Operating Income	-4.12	-1.27
Interest Expense / Income	0.4	0.29
Pretax Income	-4.76	-1.64
Net Income	-4.52	-1.56
Preferred Dividends	0.24	0.07
Net Income Common	-4.76	-1.64
Free Cash Flow	-1.03	-0.81
Gross Margin	73.20%	66.55%
Operating Margin	-314.03%	-195.54%
Profit Margin	-362.91%	-252.43%
Free Cash Flow Margin	-78.66%	-124.13%
EBITDA	-4.19	-1.19
EBITDA Margin	-319.89%	-183.39%
Depreciation & Amortization	0.16	0.15
EBIT	-4.35	-1.34
EBIT Margin	-332.02%	-207.10%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).